These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17693116)

  • 1. [Laparoscopic ovarian transposition and cryopreservation of ovarian tissue before chemo-radiotherapy for rectal cancer].
    Baron M; Resch B; Di Fiore F; Tenière P; Rives N
    Gynecol Obstet Fertil; 2007 Sep; 35(9):772-5. PubMed ID: 17693116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitizing drugs: lessons to be learned from the oxaliplatin story.
    Flatmark K; Ree AH
    J Clin Oncol; 2010 Oct; 28(29):e577-8; author reply e581-3. PubMed ID: 20733124
    [No Abstract]   [Full Text] [Related]  

  • 3. Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?
    Glynne-Jones R; Sebag-Montefiore D
    J Clin Oncol; 2010 Oct; 28(29):e579-80; author reply e581-3. PubMed ID: 20733130
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
    Glynne-Jones R; Meadows H; Wood W
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined cetuximab, capecitabine, oxaliplatin, and radiotherapy in rectal cancer: Dr. Jekyll or Mr. Hyde? In regard to Rödel et al. (Int J Radiat Oncol Biol Phys 2008;70:1081-1086.).
    Azria D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):959-60; author reply 960. PubMed ID: 18514789
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
    Fakih MG
    Ann Oncol; 2006 Jun; 17(6):1029-30; author reply 1030-1. PubMed ID: 16384877
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in MRI-staged rectal cancer.
    Glynne-Jones R
    Lancet Oncol; 2010 Mar; 11(3):213-4. PubMed ID: 20202602
    [No Abstract]   [Full Text] [Related]  

  • 8. Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer.
    Widder J; Herbst F; Scheithauer W
    Acta Oncol; 2005; 44(8):921-3. PubMed ID: 16332603
    [No Abstract]   [Full Text] [Related]  

  • 9. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
    Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment for rectal cancer.
    Zhu AX; Willett CG
    Semin Oncol; 2005 Feb; 32(1):103-12. PubMed ID: 15726512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined-modality therapy for rectal cancer: future prospects.
    Czito BG; Willett CG; Bendell JC
    Clin Colorectal Cancer; 2007 Sep; 6(9):625-33. PubMed ID: 17945034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.
    Lin JZ; Zeng ZF; Wu XJ; Wan DS; Chen G; Li LR; Lu ZH; Ding PR; Pan ZZ
    J Int Med Res; 2010; 38(2):645-54. PubMed ID: 20515578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
    Rödel C; Arnold D; Hipp M; Liersch T; Dellas K; Iesalnieks I; Hermann RM; Lordick F; Hinke A; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1081-6. PubMed ID: 17881150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy and rectal cancer].
    Michel P; Di Fiore F
    Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
    Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
    J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.
    Heudel P; Romestaing P; Barbet N; Falandry C; You B; Glehen O; Freyer G
    Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):369-74. PubMed ID: 18406583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of novel agents into combined-modality treatment for rectal cancer patients.
    Rödel C; Sauer R
    Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current options for the management of rectal cancer.
    O'Neil BH; Tepper JE
    Curr Treat Options Oncol; 2007 Oct; 8(5):331-8. PubMed ID: 18181024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.
    Ugidos L; Delgado S; Conill C; Ginés A; Gallego R; Ayuso JR; Miquel R; Tosca M; de Lacy A; Castells A; Maurel J
    Invest New Drugs; 2009 Jun; 27(3):262-8. PubMed ID: 18923810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.
    Sanghera P; Ho K; Muscroft T; Hartley A
    Br J Radiol; 2007 Aug; 80(956):e170-2. PubMed ID: 17762049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.